glp-1 weight loss injection therapy New Guidelines on Drugs for Obesity Released GLP-1 and weight loss injections

Further dose escalation occurs in 2.5 mg increments at minimum four-week intervals up to a maximum of 15 mg weekly

Gastrointestinal Issues: Nausea, vomiting, and diarrhea often happen when starting treatment

Role of AP1 and AP2 in cell type-specific transcription

Step 3: Medication Semaglutide Delivered to Home Once prescribed, your medication is sent directly to your residence

Patients should be referred to health coaches, dietitians, physiotherapists, or online weight management programmes for additional support

The ministry, however, emphasized that type 2 diabetes and obesity remain preventable and reversible conditions